Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
暂无分享,去创建一个
Johan Lindberg | Kamila Czene | Jonas Bergh | Juha Kere | Johan Hartman | Daniel Klevebring | J. Kere | K. Czene | J. Lindberg | J. Bergh | J. Hartman | D. Klevebring | Gustaf Rosin | Ran Ma | Irma Fredriksson | Ran Ma | G. Rosin | I. Fredriksson
[1] T. Taguchi,et al. Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression , 2009, Cancer science.
[2] I. Weissman,et al. Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia , 2012, Science Translational Medicine.
[3] Corbin E. Meacham,et al. Tumour heterogeneity and cancer cell plasticity , 2013, Nature.
[4] Guy S. Salvesen,et al. SnapShot: Caspases , 2011, Cell.
[5] L. Dodd,et al. Intratumoral heterogeneity in primary breast carcinoma: Study of concurrent parameters , 1997, Journal of surgical oncology.
[6] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[7] C. Blanpain,et al. Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.
[8] Kornelia Polyak,et al. Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer , 2010, Clinical Cancer Research.
[9] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[10] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[11] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[12] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Dontu,et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.
[14] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[15] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[16] M. Gönen,et al. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.
[17] R. Datar,et al. Genetic and epigenetic analysis of putative breast cancer stem cell models , 2013, BMC Cancer.
[18] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[19] Markus Thomas,et al. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells , 2012, International journal of oncology.
[20] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[21] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.
[22] Paul A. Wiggins,et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state , 2011, Proceedings of the National Academy of Sciences.
[23] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[24] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[25] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[26] J. Salk. Clonal evolution in cancer , 2010 .